Atrion Corp

$650.50 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Atrion Corp

Atrion Corporation (Atrion) is engaged in developing and manufacturing products primarily for medical applications. The Company markets components to other equipment manufacturers for incorporation in their products and sell finished devices to physicians, hospitals, clinics and other treatment centers. Its medical products primarily serve the fluid delivery, cardiovascular and ophthalmology markets. Its fluid delivery products include valves designed to fill, hold and release controlled amounts of fluids or gasses in fields, such as anesthesia and oncology. Its cardiovascular product, Myocardial Protection System (MPS3), is a technology used in the open-heart surgery that delivers fluids and medications, mixes critical drugs, and controls temperature and pressure. Its ophthalmic products include specialized medical devices that disinfect contact lenses. Atrion also manufacture a line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults.

Stock Analysis

last close $617.1
1-mo return -11.8%
3-mo return -13.1%
avg daily vol. 3.52T
52-week high 805.62
52-week low 579.96
market cap. $1.1B
forward pe -
annual div. 7.8
roe 13.5%
ltg forecast -
dividend yield 1.26%
annual rev. $157M
inst own. 67.3%

Subscribe now for daily local and international financial news